Uncategorized
Advertisement
Susan Quaggin is the winner of the 2024 John P. Peters Award from the American Society of Nephrology.
FLOW trial results showed that semaglutide has significant benefits for kidney disease events, CV outcomes, and mortality.
Patients with COVID-19–associated AKI seem to have better outcomes than those with AKI related to other respiratory ...
Bhupinder Singh and Stewart Turner discussed serum bicarbonate concentrations in patients with CKD and metabolic acidosis.
Recognizing and managing concurrent gout and CKD is important for improving outcomes but can be difficult.
A retrospective study examined whether SGLT2is are associated with cardiorenal benefits for patients with type 1 diabetes.
DaVita honored 54 of its nephrology nurses with the DAISY Award for Extraordinary Nurses during National Nurses Week.
Could urinary podocyte stress biomarker be a surrogate marker of podocyte injury in diabetic kidney disease (DKD)?
Researchers investigated COVID-19 diagnoses and related hospitalization or death in dialysis patients.
A whole food, plant-based diet has shown benefits for patients with chronic kidney disease (CKD).
Medicare Part D spending on GLP-1 drugs has soared to $5.7 billion, straining Medicare spending.
APRIL has emerged as a critical factor in the pathogenesis of IgAN and is the focus of several clinical development programs.
Studies have suggested physical activity has beneficial effects on health-related outcomes in kidney transplant patients.
AstraZeneca has removed tozorakimab from its phase 2 pipeline for diabetic kidney disease.
Researchers examined racial differences in rates of living donor kidney transplant, including center characteristics.
A study examined the association of COVID-19 disease vs vaccination with kidney function and glomerular disease activity.
Potential living kidney donors may be unprepared for possible negative outcomes following donation.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.